Products

Services

Applications

Company

Applications
Applications
Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging, cancer, and neurodegeneration research.
Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging.
Research & Translation
Biopharma Research
Clinical Development

Products
Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.
View Our Additional Services
NeuroLens®
Neuron Cell-Death Test
RNA Clarity™
RNA Vaccine QC
MethylMap™
Native-Read Methylation Sequencing

Services
Services
End-to-end sequencing services supporting genomic, epigenomic, and transcriptomic analysis, from experimental design and assay development to bioinformatics, interpretation, and data delivery.
Native-Read Multiomic Sequencing
Direct Whole Methylome Sequencing (gDNA)
Direct Methylation Sequencing (cfDNA)
Direct Targeted Methylation Sequencing (gDNA)
Whole Genome Sequencing
RNA Sequencing
Direct RNA Sequencing
cDNA Sequencing
Specialized Services
Telomere Sequencing
Proteomics (available soon)

Applications
Applications
Explore how our products and services help solve difficult biological and genomic problems, from liquid biopsy signals to complex regions and emerging biomarker development.
Hard-to-Sequence Genes & Complex Regions
Liquid Biopsy cfDNA Analysis
Targeted Panel Development

Company
Company
Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
About Us
Team

Development & Validation

Renew helps teams advance complex sequencing workflows from early development through clinical, regulatory, and operational readiness. By integrating wet-lab development, bioinformatics, and regulatory-aligned quality systems, we generate fit-for-purpose evidence from the start.

Specialized Support For Complex Sequencing Workflows

Long-read sequencing reveals biological signals that conventional methods often miss, but translating those signals into clinical assays requires more than sequencing alone. Renew combines clinical Nanopore expertise, internal R&D, and sample strategy to help partners move complex workflows from concept to clinical deployment.

Clinical Nanopore Translation

Advance ONT-based workflows through long-read expertise, native-read applications, and clinical translation.

R&D-Driven Development

Develop, optimize, and characterize complex assays before validation or regulated deployment.

Sample Strategy for Validation

Plan cohort access, sample feasibility,
and evidence generation for complex validation studies.